Trials / Recruiting
RecruitingNCT06893055
Strength-Endurance Circuit Training in Parkinson's Disease
Strength-Endurance Circuit Training in Parkinson's Disease: Effects on Disease Severity, Physical Performance, Blood Biomarkers and Quality of Life.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- General University Hospital, Prague · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to determine whether adding strength training to aerobic training has a comparable or greater effect on the clinical status of Parkinson's disease patients than a standalone aerobic training. \- Does combined strength-endurance circuit training provide added benefits to physical performance, disease severity, blood biomarkers, and quality of life in PD patients compared to standalone aerobic training? Participants will: * undergo outcome measurements before and after the 12-week intervention and a 3-month follow-up measurement, * visit the clinic twice a week for 1-hour training sessions. * selected patients will be given a smartwatch with a pedometer that will count their average number of steps before, during and after the training period
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Strength-Endurance Training | The intervention for the experimental Strength-Endurance group includes warm-up, three laps of strength and endurance exercises and cool-down. The training program lasts 3 months and includes two 1-hour training sessions per week, for a total of 24 sessions. |
| OTHER | Endurance Training | The intervention for the control Endurance training group includes warm-up, three laps of endurance exercises and cool-down. The training program lasts 3 months and includes two 1-hour training sessions per week, for a total of 24 sessions. |
Timeline
- Start date
- 2025-03-03
- Primary completion
- 2026-12-01
- Completion
- 2027-03-01
- First posted
- 2025-03-25
- Last updated
- 2025-04-09
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT06893055. Inclusion in this directory is not an endorsement.